Blog Articles

In the previous blog, we discussed common issues in medical device developments which lead to delays in getting the product to market. This blog covers some strategies on how to spot those issues and how to resolve them.

In part one of a two part series we take a look at why medical device developments are often delayed, with some common causes that we have seen over the years. In part two, we look at some solutions to ensure that development plans stay on schedule.

Robotic-assisted surgery has been making its way into the operating room (OR) for decades, boosting minimally invasive general surgery, enhancing orthopaedics, and enabling precision-guided catheter systems—with continued improvements leading to complex systems such as Intuitive’s market-leading da Vinci.

At Springboard we are combining our technical ability and charitable efforts to work on a project with Humanos3D, a charity based in Medellin, Colombia. Some of the problems the charity are trying to solve are more complex and require iterative design and engineering expertise to meet the needs of the user; Springboard chose to take on one of the unsolved cases. We started out with a plank of wood….

Governments and companies across the world have made ambitious commitments to reducing their environmental impact. For example, 55 countries at the COP26 climate change conference in November 2021 committed to developing low carbon health care systems; and 20 have committed to developing net zero healthcare systems, with deadlines ranging from 2030 to 2050[1]. What is the pharmaceutical industry doing to help meet these targets, and is it enough?

The on-body delivery system (OBDS) market is changing rapidly, and it has become clear that OBDS devices are critical to the delivery of some new drugs in development.

You know that horrid juddering noise that windscreen wipers make sometimes? This is caused by alternate sticking and slipping of rubber on glass. The same phenomenon occurs with the rubber plunger in a glass syringe, albeit with more serious consequences including uncomfortable injections, variability in dosing, and wastage of drug.

MedTech Navigator’s “The Future of Diabetes Care” seminar highlighted that whilst developments in the treatment of diabetes have been extraordinary there is still huge demand for further innovation. In particular, user centric solutions are needed to reduce the burden of this relentless condition.

Gene therapies are at the forefront of medical science, looking to treat the rarest of diseases that collectively afflict millions of people worldwide.

Introduction

The ISO 11608 family of standards for Needle-based Injection System (NISs) was recently updated for the first time since 2014. Many of the changes make the standards better suited to the newer types of NISs which are becoming increasingly common, such as On Body Delivery Systems (OBDSs) and NISs containing electronics.